Bank your cells now! Contact us for more information!
ABOUT US
LongevityBank Pte Ltd (201914822D)
​
Registered Office (Singapore):
#08-22 One Commonwealth
1 Commonwealth Lane
Singapore 149544
​
IPSC Depository Sdn Bhd (1332047-T)
IPSC depository:
D7-1-16 & D7-1-17, Bangunan Perdagangan D7,
800 Jln Sentul, Sentul,
51000 Kuala Lumpur,
Wilayah Persekutuan Kuala Lumpur,
Malaysia
GMP Facility: 12, Jalan Permas 9/16, Bandar Baru Permas Jaya, 81750 Johor Bahru, Johor, Malaysia
Contact Number: +607-3824911
Email: cellsafe-enquiry@ipscbank.sg
IPSC Depository Sdn Bhd and LongevityBank Pte Ltd are subsidiaries of CytoMed Therapeutics Limited (NASDAQ: GDTC) which mainly focuses on the banking of our customers' cells such as PBMCs, iPSCs and MSCs for future usage.
CytoMed Therapeutics is a deep tech company incorporated in 2018 which focuses on translating its patented technologies into “off-the-shelf” immunotherapeutics for a wide range of cancers. CytoMed also engages in generating induced pluripotent stem cells (iPSCs) and developing them into cellular therapeutics using our proprietary technologies for our customers. CytoMed has built its own state-of-the-art GMP facility to support cell therapies and cell banking activities.
​
Visit www.cytomed.sg to learn more about our parent company.
CytoMed Therapeutics operate in a 3-storey all-in-one GMP manufacturing facility which includes Quality Control (QC) Lab, Research & Development (R&D) Lab, GMP-certified Production Facility. LongevityBank operates a licensed stem cell banking facility.